Literature DB >> 10408495

Mortality during adjuvant treatment of early breast cancer with cyclophosphamide, methotrexate, and fluorouracil. International Breast Cancer Study Group.

M Colleoni, K N Price, M Castiglione-Gertsch, R D Gelber, A S Coates, A Goldhirsch.   

Abstract

Combined chemotherapy for early breast cancer with cyclophosphamide, methotrexate, and fluorouracil has low associated mortality, but related deaths were seen among women aged 65 years or older in International Breast Cancer Study Group trials.

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10408495     DOI： 10.1016/s0140-6736(99)02015-2

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


  7 in total

Review 1.  The role of myelopoietic growth factors in managing cancer in the elderly.

Authors:  Lodovico Balducci; Ignazio Carreca
Journal:  Drugs       Date:  2002       Impact factor: 9.546

2.  Classical cyclophosphamide, methotrexate, and fluorouracil chemotherapy is more effective in triple-negative, node-negative breast cancer: results from two randomized trials of adjuvant chemoendocrine therapy for node-negative breast cancer.

Authors:  Marco Colleoni; Bernard F Cole; Giuseppe Viale; Meredith M Regan; Karen N Price; Eugenio Maiorano; Mauro G Mastropasqua; Diana Crivellari; Richard D Gelber; Aron Goldhirsch; Alan S Coates; Barry A Gusterson
Journal:  J Clin Oncol       Date:  2010-05-10       Impact factor: 44.544

3.  Oncologists' recommendations for adjuvant therapy in hormone receptor-positive breast cancer patients of varying age and health status.

Authors:  Arash Naeim; F Lennie Wong; Sumanta K Pal; Arti Hurria
Journal:  Clin Breast Cancer       Date:  2010-04       Impact factor: 3.225

4.  Compliance and toxicity of adjuvant CMF in elderly breast cancer patients: a single-center experience.

Authors:  Ermelinda De Maio; Adriano Gravina; Carmen Pacilio; Gerardo Amabile; Vincenzo Labonia; Gabriella Landi; Francesco Nuzzo; Emanuela Rossi; Giuseppe D'Aiuto; Immacolata Capasso; Massimo Rinaldo; Brunello Morrica; Massimo Elmo; Massimo Di Maio; Francesco Perrone; Andrea de Matteis
Journal:  BMC Cancer       Date:  2005-03-24       Impact factor: 4.430

Review 5.  Adjuvant Systemic Therapy in Older Breast Cancer Women: Can We Optimize the Level of Care?

Authors:  Anna Rachelle Mislang; Laura Biganzoli
Journal:  Cancers (Basel)       Date:  2015-07-03       Impact factor: 6.639

6.  Evaluation of the Survival Benefit of Different Chemotherapy Regimens in Patients with T1-2N0 Triple-Negative Breast Cancer.

Authors:  Hyun-Ah Kim; Min-Ki Seong; Eun-Kyu Kim; Eunyoung Kang; Seho Park; Min Hee Hur; Byung Joo Song; Woo Chul Noh
Journal:  J Breast Cancer       Date:  2015-09-24       Impact factor: 3.588

Review 7.  The role of radiation therapy and systemic therapies in elderly with breast cancer.

Authors:  Valerio Nardone; Sara Falivene; Francesca Maria Giugliano; Marcella Gaetano; Pasqualina Giordano; Matteo Muto; Bruno Daniele; Cesare Guida
Journal:  Transl Cancer Res       Date:  2020-01       Impact factor: 1.241
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.